PRP-fibrinogen gel-like chondrocyte carrier stabilized by TXA-preliminary study

Cell and Tissue Banking

Volumn 14, Issue 1, 2013, Pages 133-140

  Sitek, Patrycja ^a   Wysocka Wycisk, Aleksandra ^a   Kępski, Fabian ^a   Król, Dorota ^a   Bursig, Henryk ^a   Dyląg, Stanisław ^a  

^a Regional Blood Center   (Poland)

Author keywords

Aprotinin; Chondrocytes; Platelet rich plasma; Tranexamic acid

Indexed keywords

EID: 84873740821     PISSN: 13899333     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10561-011-9290-0     Document Type: Article

References (24)

1. Akeda K, An HS, Okuma N, Attawia M, Mizamoto K, Thonar EJ, Leny ME, Sah RL, Masuda K (2006) Platelet rich plasma stimulates porcine articular chondrocyte proliferation and matrix biosynthesis. Osteoarthtritis Cartilage 12:1272-1280
2. Beierlein W, Scheule AM, Antoniadis G, Braun C, Schosser R (2000) An immediate, allergic skin reaction to aprotinin after reexposure to fibrin sealant. Transfusion 40:302-305
3. Casati V, Guzzon D, Oppizzi M, Cossolini M, Torri G, Calori G, Alfieri O (1999) Hemostatic effects of aprotinin, tranexamic acid and epsilon aminocaproic acid in primary cardiac surgery. Ann Thorac Surg 6:2252-2256
4. Cholewinski E, Dietrich M, Flanagan TC, Schmitz-Rode T, Jockenhoevel S (2009) Tranexamic acid - an alternative to aprotinin in fibrin - based cardiovacular tissue engineering. Tissue Eng 15:1-11
5. Crane D, Everts P (2008) Platelet rich plasma (PRP) matrix grafts. PRP application techniques in musculoskeletal medicine utilize the concentrated healing components of a patient's own blood - reintroduced into a specific site - to regenerate tissue and the healing process. Pract Pain Manag 1-10
6. Dunn CJ, Goa KL (1999) Tranexamic acid: a review of its use in surgery and other indications. Drugs 6:1005-1032
7. Fortier L, Brofman P, Nixon A, Mohammed H (1998) Disparate chondrocyte metabolism in three-dimensional fibrin cultures derived from autogenous or commercially manufactured fibrinogen. AJVR 59:514-520
8. Freymillar EG, Aghaloo TL (2004) Platelet-rich plasma: ready or not? J Oral Maxillofac Surg 62:484-488
9. Gimeno F, Gatto S, Ferro J, Croxatto J, Gallo J (2006) Preparation of platelet rich plasma as a tissue adhesive for experimental transplantation in rabbits. Thromb J 4:1-7
10. Graziani F, Cei S, Ducci F, Giȩci MR, Donos N, Gabriele M (2005) In vitro effects of different concentration of PRP on primary bone and gingival cell lines. Preliminary results. Minerva Stomatol 54:15-22
11. Haberhauer M, Zernia G, Deiwick A, Posel C, Bader A, Huster D, Shulz R (2008) Cartilage tissue engineering in plasma whole blood scaffolds. Adv Mater 20:2061-2067
12. Kanno T, Takahashi T, Tsujiswa T, Ariyoshi W (2005) Platelet - rich plasma enhances human osteoblast - like proliferation and differentiation. J Maxifollac Surg 63:362-369
13. Kawasaki K, Sugihara S, Nishida K, Ozaki T, Yoshida A, Ohtsuka A, Inoue H (2004) Hoechst 33342 is a useful cell tracer for a long-term investigation of articular cartilage repair. Arch Histol Cytol 67:13-19
14. Kawase T, Okuda K, Wolff L, Yoshie H (2003) Plasma-rich plasma derived fibrin clot formation stimulates collagen synthesis in periodontal ligament and osteoblastic cells in vitro. J Periodontal 74:856-864
15. Kirilak Y, Pavlos NJ, Willers CR, Han R, Feng H, Xu J, Asokanathan N, Steward GA, Henry P, Wood D, Zheng MH (2006) Fibrin sealant promotes migration and proliferation of human articular chondrocytes: possible involvement of thrombin and protease activated receptors. Int J Mol Med 4:551-558
16. Marx R (2001) Platelet rich plasma (PRP): what is PRP and what is not PRP? Implant Dent 4:225-228
17. Meinhart J, Fussenegger M, Hobling W (1999) Stabilization of fibrin-chodrocyte constructs for cartilage reconstruction. Ann Plast Surg 42:673-678
18. Mitsuyama H, Mishima S, Kondo S, Ishiguro N, Amiel D (2006) Charakterization of a scaffold composed of platelet-rich plasma for autologous chondrocyte implantation. Dissertation, University Graduate of medicine, Nagoya
19. Okuda K, Kawase T, Momose M, Murata M, Saito Y, Suzuki H et al (2003) Platelet rich plasma contains high levels of platelet - derived growth factors and transforming growth factor - beta and modulates the proliferation of periodontally related cells in vitro. J Periodontol 74:849-885
20. Roukis TS, Zgonis T, Tiernan B (2006) Autologous platelet-rich plasma for wound ond osseous healing: a review of the literature and commercially available products. Adv Ther 23:218-237
21. Verstraete M (1985) Clinical application of inhibitors of fibrinolysis. Drugs 3:236-261
22. Waldow T, Krutzsch D, Wils M, Plotze K, Matschke K (2009) Low dose aprotinin and low dose tranexamic acid in elective cardiac surgery with cardiopulmonary bypass. Clin Hemorheol Microcirc 4:269-277
23. Wang HL, Avita G (2007) Platelet rich plasma: myth or reality? EJPD 1:192-194
24. Wysocka A, Mann K, Bursig H, Dec J, GaÅdzik TS (2010) Chondrocyte suspension in fibrin glue. Cell Tissue Bank 11:209-215